title: Administration of zidovudine during primary HIV-1 infection may be associated with a less vigorous immune response.
authors.forename: B
authors.initials: B
authors.lastname: Tindall
authors.forename: A
authors.initials: A
authors.lastname: Carr
authors.forename: D
authors.initials: D
authors.lastname: Goldstein
authors.forename: R
authors.initials: R
authors.lastname: Penny
authors.forename: D A
authors.initials: DA
authors.lastname: Cooper
mesh_terms: D016827:CD8 Antigens; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D015497:HIV-1; D006801:Humans; D007107:Immune System / Q000187:drug effects; D008297:Male; D016176:T-Lymphocyte Subsets / Q000187:drug effects / Q000276:immunology; D015215:Zidovudine / Q000009:adverse effects*
chemical_list: D016827:CD8 Antigens; D015215:Zidovudine